Cancer research is a subject that is consistently expanding with new discoveries and information from doctors and scientists around the world. Oncotarget makes finding this information all in one place simple and organized.
Established in 2010, Oncotarget is a weekly peer-reviewed medical journal with open access. Oncotarget features articles written by physicians and medical scientists that cover all areas of oncology. Their mission is to make fresh scientific findings widely and readily available to physicians and patients alike. Oncotarget’s popularity has steadily increased over the years because of its insightful and constructive peer-review system. Articles can be trusted to provide honest and well-researched information from reputable authors.
Oncotarget was founded by Mikhail Blagosklonny, a former professor of oncology and scientist who studies cancer and aging. While his mission in starting Oncotarget was to make scientific findings about cancer more accessible, his ultimate goal is to end the disease all together. The Oncotarget journal is bringing this ultimate goal just one step closer by including such an extensive collection of oncology information. The journal covers all aspects of oncology from causes of cancer to treatment protocols for cancer. The journal also gives a special focus to newly found therapeutic practices and patient’s quality of life.
Clearly, Oncotarget’s system is working; the journal earned an Impact Factor of 5.168 for the 2016 publication year. Due to Oncotarget’s steady rise in popularity, it has recently expanded to include information on topics such as neuroscience, endocrinology, cardiology and metabolism. Learn more at researchgate.net